Star Health and Allied Insurance Company , India's leading standalone health insurer, has issued a postal ballot notice seeking shareholder approval for several key business matters, including executive remuneration and board appointments.

Remuneration for Non-Executive Chairperson

The company is requesting approval for an annual remuneration of Rs. 30.00 lakh for Mr. Rajeev Kher, who serves as the Non-Executive Independent Director and Chairperson of the Board. Mr. Kher, a former Indian Administrative Service officer with over four decades of experience in international trade, commerce, and policy-making, was appointed to the board in June 2024 and as Chairperson in July 2025.

MD & CEO Compensation Package

For Mr. Anand Roy, the Managing Director & Chief Executive Officer (MD & CEO), Star Health is seeking approval for his FY 2025-26 remuneration package. The proposed compensation includes:

The variable pay and ESOPs are subject to a maximum of 100% of the fixed pay, with the ESOP grant to be based on fair market price at the time of allocation in FY 2026-27.

New Whole-time Director Appointments

The company is also seeking shareholder approval for the appointment of two senior executives as Whole-time Directors:

1. Mr. Himanshu Walia, Chief Marketing Officer

   • Proposed annual package: Rs. 3.33 crore (fixed pay)
   • Variable pay structure similar to the MD & CEO

2. Mr. Amitabh Jain, Chief Operating Officer

   • Proposed annual package: Rs. 3.71 crore (fixed pay)
   • Variable pay structure similar to the MD & CEO

Both appointments are for a five-year term, subject to IRDAI approval.

Employee Stock Option Scheme

Additionally, shareholders will be asked to note a statement regarding the accounting methods for the company's employee stock option scheme.

Voting Process

The e-voting period for these resolutions is scheduled from August 2 to August 31, 2025. Results of the postal ballot will be announced by September 1, 2025. All appointments and remuneration proposals are subject to approval from the Insurance Regulatory and Development Authority of India (IRDAI).

These proposed changes reflect Star Health's commitment to aligning executive compensation with company performance and shareholder interests, while also strengthening its leadership team to drive future growth in the competitive health insurance market.

Star Health and Allied Insurance Company , a prominent player in the Indian insurance sector, has set ambitious targets for its financial performance while reporting robust growth in its latest quarterly results.

Financial Targets and Strategy

Star Health has announced its aim to achieve and maintain a return on equity (ROE) of 15-16% or higher by the fiscal year 2028. Nilesh Kambli, the company's Chief Financial Officer, emphasized the focus on sustainable profitability and controlling expense ratios to improve operating profitability.

Market Position

The company has successfully maintained a 33% annual market share, driven by its extensive agency network and digital platform. This strong market presence has been particularly notable in tier 2 and tier 3 cities, where Star Health has established itself as a leader in the insurance sector.

Q1 Financial Performance

Star Health reported impressive financial results for the first quarter:

The company's profit after tax saw a significant increase of 44.00%, rising from ₹304.00 crore to ₹438.00 crore. The return on equity also improved, reaching 4.90% compared to 3.80% in the previous year. Gross Written Premium, a key indicator of insurance business growth, rose by 13.00% year-on-year to ₹3,936.00 crore.

Business Insights

CFO Nilesh Kambli provided additional insights into the company's operations:

• Portability accounts for only 10% of new business, indicating strong customer retention and acquisition of new policyholders.
• The company's leadership position in tier 2 and tier 3 cities highlights its strong penetration in these markets.

Market Response

The positive financial results and future outlook were well-received by the market. Star Health's shares closed 4.55% higher at ₹446.15, reflecting investor confidence in the company's performance and strategy.

As Star Health continues to focus on sustainable growth and profitability, its performance in the coming quarters will be closely watched by investors and industry analysts alike.